Jean Gariépy Selected Research

Jean Gariépy Research Topics

Disease

21	Neoplasms (Cancer) 11/2020 - 12/2002
4	Inflammation (Inflammations) 01/2021 - 04/2010
2	Arthritis (Polyarthritis) 01/2022 - 08/2014
2	Adenocarcinoma 07/2020 - 07/2009
2	Melanoma (Melanoma, Malignant) 04/2015 - 02/2010
2	Carcinoma (Carcinomatosis) 03/2014 - 12/2012
2	Colonic Neoplasms (Colon Cancer) 04/2010 - 12/2003
1	Knee Osteoarthritis 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 07/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Hepatitis 01/2017
1	Infections 08/2014
1	Multiple Sclerosis 08/2014
1	Hypersensitivity (Allergy) 08/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2014
1	Colitis-Associated Neoplasms 04/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2009
1	Autoimmune Diseases (Autoimmune Disease) 06/2002

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2016 - 12/2003
5	Nucleotide AptamersIBA 01/2022 - 02/2009
5	Peptides (Polypeptides)IBA 07/2010 - 05/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
4	Carcinoembryonic AntigenIBA 10/2018 - 12/2012
3	LigandsIBA 01/2016 - 12/2010
3	AntibodiesIBA 01/2016 - 12/2012
3	EpitopesIBA 07/2010 - 06/2002
3	GlycopeptidesIBA 07/2010 - 12/2003
2	phytochlorinIBA 10/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2012 - 12/2002
2	Monoclonal AntibodiesIBA 12/2010 - 05/2007
2	OligonucleotidesIBA 12/2010 - 02/2009
2	Glycoproteins (Glycoprotein)IBA 07/2009 - 12/2003
2	Surface Antigens (Surface Antigen)IBA 02/2009 - 12/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2020
1	RamucirumabIBA 07/2020
1	Cisplatin (Platino)FDA LinkGeneric 07/2020
1	Fluorouracil (Carac)FDA LinkGeneric 07/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018
1	Concanavalin AIBA 01/2017
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	Poly I-CIBA 01/2016
1	VasculotideIBA 06/2015
1	Angiopoietin-1IBA 06/2015
1	L 644711 (B-3(+))IBA 03/2014
1	CytokinesIBA 12/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 12/2010
1	Single-Stranded DNA (DNA, Single Stranded)IBA 12/2010
1	Tumor Biomarkers (Tumor Markers)IBA 12/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2010
1	VaccinesIBA 04/2010
1	Chloride Channels (Chloride Channel)IBA 04/2010
1	SaporinsIBA 02/2010
1	Dacarbazine (DIC)FDA LinkGeneric 02/2010
1	AcidsIBA 02/2010
1	DisaccharidesIBA 07/2009
1	MucinsIBA 07/2009
1	Tn antigenIBA 07/2009
1	chlorinIBA 02/2009
1	Polysaccharides (Glycans)IBA 02/2009
1	Pharmaceutical PreparationsIBA 02/2009
1	His-His-His-His-His-His ((His)6)IBA 05/2007
1	Aligeron (AS 2)IBA 05/2007
1	Immunoglobulin Fab FragmentsIBA 05/2007
1	tumor-associated antigen 72IBA 05/2007
1	TransferasesIBA 12/2003
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2003
1	Epidermal Growth Factor (EGF)IBA 12/2002

Therapy/Procedure

1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2020
1	Drug Therapy (Chemotherapy) 07/2020
1	Precision Medicine 01/2020
1	Transplantation 08/2014
1	Photochemotherapy (Photodynamic Therapy) 02/2009
1	Radiotherapy 05/2007